only marginally significantP -value = 0.061
After EPLAs, non-papilloma patients had significant improvements in SNOT-22 and VAS ( P -values = 0.012 and 0.012, respectively), while those with papillomas had only marginally significant improvements in VAS ( P -value = 0.061).